Meng Jin

机构：Institute of Genetics and Developmental Biology, Beijing Children’s Hospital, Second Affiliated Hospital of Zhejiang University, University of Chinese Academy of Sciences, First Affiliated Hospital Zhejiang University · ORCID：0000-0002-8918-9481

发表论文 51 篇 · 总被引 599 次 · h-index 13

代表论文

• Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease (2021 · Carbohydrate Polymers · 被引 47)
• SP1-mediated up-regulation of lncRNA TUG1 underlines an oncogenic property in colorectal cancer (2022 · Cell Death and Disease · 被引 24)
• Hyperuricemia induces lipid disturbances by upregulating the CXCL-13 pathway (2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 16)
• Long-term Disease Behavior and Surgical Intervention Analysis in Hospitalized Patients With Crohn’s Disease in China: A Retrospective Cohort Study (2021 · Inflammatory Bowel Diseases · 被引 9)
• Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study (2022 · Gut and Liver · 被引 8)
• LESS IS MORE: classified management of hypertriglyceridemia-induced acute pancreatitis on the basis of a propensity score matching cohort study (2025 · Lipids in Health and Disease · 被引 5)